Skip to content

The role and mechanism of external counterpulsation in the prevention of hypertension and cardiovascular and cerebrovascular disease in patients with hypertension

The role and mechanism of external counterpulsation in the prevention of hypertension and cardiovascular and cerebrovascular disease in patients with hypertension

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029488
Enrollment
Unknown
Registered
2020-02-02
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

experimental group:EECP and standard medication

Sponsors

Health Committee of Shandong Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) a new finding of BP >= 140/90 mmHg or 24-h ambulatory BP monitoring >= 130/80 mmHg or previous diagnosis of hypertension with evidence of BP not adequately controlled by the current therapy; 2) BP 18 years.

Exclusion criteria

Exclusion criteria: Secondary hypertension; participation in moderate-intensity exercise for 20 min, >= 2 times per week; history of deep vein thrombosis, phlebitis, stasis ulcer, or pulmonary embolism; cardiac arrhythmia that would interfere with electrocardiography synchronization of EECP; severe heart failure; aortic valve insufficiency, regurgitation, dissection, or aneurysm; any acute illness that may affect BP when enrolled; diagnosed glaucoma; and pregnancy.

Design outcomes

Secondary

MeasureTime frame
blood pressure;Cardio-cerebral vascular event rate;

Countries

China

Contacts

Public ContactLin Shen

Department of Geriatric Medicine, Qilu Hospital of Shandong University

slmm321@126.com+86 18560082257

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026